Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.38% |
| 2 | Consumer Discretionary | 1.03% |
| 3 | Financials | 0.75% |
| 4 | Healthcare | 0.67% |
| 5 | Communication Services | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
CALL
Nektar Therapeutics
NKTR
$2.52B
| $38.3K | ﹤0.01% |
2,060
-6,700
| -76% | -$141K |
|
11452
Minerva Neurosciences
NERV
$259M
| $38.1K | ﹤0.01% |
11,938
-4,743
| -28% | -$12.8K |
|
11453
PUT
China Automotive Systems
CAAS
$159M
| $38K | ﹤0.01% |
+10,700
| New | +$39.4K |
|
|
DADA
11454
DELISTED
Dada Nexus
DADA
| $37.9K | ﹤0.01% |
30,114
-59,945
| -67% | -$108K |
|
11455
CALL
Ribbon Communications
RBBN
$363M
| $37.8K | ﹤0.01% |
11,500
-200
| -2% | -$608 |
|
|
UBX
11456
CALL
DELISTED
Unity Biotechnology
UBX
| $37.7K | ﹤0.01% |
+27,900
| New | +$42.4K |
|
11457
CALL
Vivani Medical
VANI
$128M
| $37.4K | ﹤0.01% |
29,700
+4,600
| +18% | +$7.89K |
|
|
CUTR
11458
DELISTED
Cutera, Inc.
CUTR
| $37.4K | ﹤0.01% |
24,738
-27,944
| -53% | -$56.2K |
|
11459
PUT
US Global Investors
GROW
$41.4M
| $37.1K | ﹤0.01% |
14,200
+200
| +1% | +$534 |
|
|
WIMI
11460
PUT
WiMi Hologram Cloud
WIMI
$25M
| $37K | ﹤0.01% |
4,410
-230
| -5% | -$1.98K |
|
11461
XWELL
XWEL
$8.55M
| $36.8K | ﹤0.01% |
20,419
+5,592
| +38% | +$9.54K |
|
11462
AtaiBeckley Inc
ATAI
$2.74B
| $36.8K | ﹤0.01% |
27,634
-29,059
| -51% | -$52.4K |
|
11463
Kartoon Studios
TOON
$40.3M
| $36.5K | ﹤0.01% |
35,458
-165,883
| -82% | -$191K |
|
11464
Palladyne AI
PDYN
$296M
| $36.4K | ﹤0.01% |
+22,742
| New | +$39.1K |
|
11465
CALL
SCYNEXIS
SCYX
$56.4M
| $36.2K | ﹤0.01% |
+2,263
| New | +$35K |
|
|
DHC
11466
Diversified Healthcare Trust
DHC
$1.95B
| $35.6K | ﹤0.01% |
+11,672
| New | +$29.6K |
|
11467
CALL
Conduent
CNDT
$261M
| $35.5K | ﹤0.01% |
10,900
-22,800
| -68% | -$77.5K |
|
11468
PUT
Nerdy
NRDY
$88.3M
| $35.2K | ﹤0.01% |
1,407
+547
| +64% | +$18K |
|
11469
United States Antimony
UAMY
$757M
| $35K | ﹤0.01% |
+104,241
| New | +$29.1K |
|
|
NAGE
11470
PUT
Niagen Bioscience
NAGE
$261M
| $34.9K | ﹤0.01% |
12,800
+1,500
| +13% | +$5.02K |
|
|
EONR
11471
EON Resources
EONR
$25.7M
| $34.9K | ﹤0.01% |
+13,254
| New | +$31.7K |
|
|
GAU
11472
CALL
Galiano Gold
GAU
$620M
| $34.7K | ﹤0.01% |
+20,200
| New | +$33K |
|
11473
PUT
E.W. Scripps
SSP
$292M
| $34.5K | ﹤0.01% |
+11,000
| New | +$34.8K |
|
11474
CALL
Protara Therapeutics
TARA
$231M
| $34.5K | ﹤0.01% |
+16,600
| New | +$48.5K |
|
11475
American Shared Hospital Services
AMS
$10M
| $34.4K | ﹤0.01% |
10,779
-78
| -0.7% | -$247 |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass withdrew a net $65.7B in Q2 2024, closing 1,726 positions and reducing 5,607 holdings. Its most notable exit was iShares MSCI USA Quality Factor ETF, an estimated $26.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in NextEra Energy 7.299% Corporate Units worth $127M.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.